Organ Atrophy Induced by Sorafenib and Sunitinib – Quantitative Computed Tomography (CT) Evaluation of the Pancreas, Thyroid Gland and Spleen

BACKGROUND: To evaluate organ atrophy induced by sorafenib and sunitinib, we retrospectively reviewed the CT scans of renal cell carcinoma (RCC) patients receiving molecular targeted therapy (MTT) using sorafenib or sunitinib, and performed volumetric analysis of the pancreas, thyroid gland, and spl...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Hiroaki, Nasu, Katsuhiro, Minami, Manabu, Kojima, Takahiro, Nishiyama, Hiroyuki, Ishiguro, Toshitaka, Konishi, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129701/
https://www.ncbi.nlm.nih.gov/pubmed/27956943
http://dx.doi.org/10.12659/PJR.898936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129701/
https://www.ncbi.nlm.nih.gov/pubmed/27956943
http://dx.doi.org/10.12659/PJR.898936

Ejemplares similares